Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsSimonsen, G S
Monnet, D L
Sørensen, T L
Møller, J K
Kristinsson, K G
MetadataShow full item record
CitationJ. Antimicrob. Chemother. 2003, 51(2):323-31
AbstractWe determined the species distribution and prevalence of ampicillin resistance, high-level gentamicin resistance (HLGR) and vancomycin resistance among clinical enterococcal isolates from five Nordic laboratories (Bergen, Tromsø, Uppsala, Aarhus and Reykjavik). Isolates represented three different groups: (i) all blood culture isolates from 1999; (ii) consecutive in-patient isolates (maximum 40); and (iii) consecutive outpatient isolates (maximum 40) collected during March to May 2000. Antimicrobial use data were collected at the national and hospital level. A high proportion (31.4%) of Enterococcus faecium was detected among blood culture isolates, in contrast to only 4.2% among isolates from outpatients. Ampicillin resistance was not found in Enterococcus faecalis, in contrast to 48.8% in E. faecium isolates. HLGR rates varied considerably between laboratories (1.1-27.6%). Acquired vancomycin resistance was not detected. There were no significant differences in the prevalences of HLGR between in-patient and outpatient isolates at individual hospitals. A cluster of clonally related ampicillin-resistant and HLGR E. faecium isolates was demonstrated in one of the hospitals. The lowest level of hospital antimicrobial use, the lowest proportion of E. faecium and the lowest prevalence of resistance were observed in Reykjavik.The study showed a relatively low level of resistance in enterococci, as compared with most European countries and the USA. However, there were large differences between hospitals with regard to the relative proportion of E. faecium isolates, their susceptibility to ampicillin and gentamicin, as well as the prevalence of HLGR in E. faecalis isolates. This indicates a potential for further improvement of antibiotic policies, and possibly hospital infection control, to maintain the low resistance levels observed in these countries.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Genetic relatedness of Enterococcus faecalis isolates with high-level gentamicin resistance from patients with bacteraemia in the south east of Sweden 1994-2001.
- Authors: Saeedi B, Hällgren A, Isaksson B, Jonasson J, Nilsson LE, Hanberger H
- Issue date: 2004
- Genotypic diversity and epidemiology of high-level gentamicin resistant Enterococcus in a Chinese hospital.
- Authors: Qu TT, Chen YG, Yu YS, Wei ZQ, Zhou ZH, Li LJ
- Issue date: 2006 Feb
- Diversity among high-level aminoglycoside-resistant enterococci.
- Authors: Papaparaskevas J, Vatopoulos A, Tassios PT, Avlami A, Legakis NJ, Kalapothaki V
- Issue date: 2000 Mar
- A nanoplex PCR assay for the rapid detection of vancomycin and bifunctional aminoglycoside resistance genes in Enterococcus species.
- Authors: Yean CY, Yin LS, Lalitha P, Ravichandran M
- Issue date: 2007 Dec 11
- Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007.
- Authors: Protonotariou E, Dimitroulia E, Pournaras S, Pitiriga V, Sofianou D, Tsakris A
- Issue date: 2010 Jul